Robert Sabbagh Selected Research

Robert Sabbagh Research Topics

7	Neoplasms (Cancer) 11/2022 - 10/2014
6	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 06/2010
5	Renal Cell Carcinoma (Grawitz Tumor) 11/2018 - 03/2011
3	Pain (Aches) 12/2020 - 08/2002
3	Infections 01/2019 - 04/2004
2	Kidney Neoplasms (Kidney Cancer) 06/2018 - 08/2005
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018 - 01/2017
1	Fatigue 12/2020
1	Sepsis (Septicemia) 01/2019
1	Thrombosis (Thrombus) 01/2018
1	Wounds and Injuries (Trauma) 01/2017
1	Hypotension (Low Blood Pressure) 01/2017
1	Chronic Pain 05/2015
1	Adenocarcinoma 04/2012
1	Pseudomyxoma Peritonei 04/2012
1	Neoplasm Metastasis (Metastasis) 03/2011
1	Chylous Ascites 12/2005
1	Postoperative Pain 12/2005
1	Pyelonephritis 08/2005

3	Protein Isoforms (Isoforms)IBA 11/2022 - 12/2017
3	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 11/2022 - 12/2017
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2019 - 09/2012
1	Biomarkers (Surrogate Marker)IBA 11/2022
1	Prednisone (Sone)FDA LinkGeneric 12/2020
1	Abiraterone AcetateIBA 12/2020
1	E2F Transcription FactorsIBA 07/2020
1	EnzymesIBA 07/2020
1	Fosfomycin FDA Link 01/2019
1	Peptides (Polypeptides)IBA 01/2018
1	Cholic AcidIBA 01/2018
1	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2018
1	AndrogensIBA 12/2017
1	Enzyme Precursors (Zymogens)IBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2015
1	MetanephrineIBA 05/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 05/2015
1	Pain-FreeIBA 05/2015
1	Type 1 Angiotensin ReceptorIBA 07/2013
1	Angiotensin IIIBA 07/2013
1	SteroidsIBA 06/2010
1	Lidocaine (Xylocaine)FDA LinkGeneric 08/2002

8	Nephrectomy 11/2018 - 08/2005
5	Therapeutics 12/2020 - 03/2011
1	Castration 12/2020
1	Aftercare (After-Treatment) 08/2018
1	Resuscitation 01/2017
1	Hyperthermic Intraperitoneal Chemotherapy 04/2012
1	Antibiotic Prophylaxis 04/2004
1	Rectal Administration 08/2002